Laura J. Schumacher - Dec 17, 2021 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Vice Chairman
Signature
Steven L. Scrogham, attorney-in-fact for Laura J. Schumacher
Stock symbol
ABBV
Transactions as of
Dec 17, 2021
Transactions value $
-$23,660,678
Form type
4
Date filed
12/21/2021, 04:21 PM
Previous filing
Dec 20, 2021
Next filing
Dec 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Options Exercise $6.08M +103K +48.46% $58.88 316K Dec 17, 2021 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $4.3M +78.5K +24.81% $54.86 395K Dec 17, 2021 Direct
transaction ABBV Common Stock, $0.01 par value Sale -$23.1M -178K -44.99% $130.23 217K Dec 17, 2021 Direct F1
transaction ABBV Common Stock, $0.01 par value Sale -$537K -4.11K -1.89% $130.61 213K Dec 17, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (Right To Buy) Options Exercise -$6.08M -103K -100% $58.88 0 Dec 17, 2021 Common Stock 103K $0.00 Direct F3
transaction ABBV Option (Right To Buy) Options Exercise -$4.3M -78.5K -100% $54.86 0 Dec 17, 2021 Common Stock 78.5K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.56 to $130.55, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.56 to $131.09, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).